Theranostics Health, Duke Collaborate Under Grant from Komen Foundation | GenomeWeb

NEW YORK (GenomeWeb News) – Theranostics Health said today that it is collaborating with Duke University on a research effort for new prevention and treatment options for breast cancer under a recent grant from the Susan G. Komen Foundation.

The Rockville, Md.-based firm said that it has been collaborating with Duke investigator Victoria Seewaldt for the past year. That research formed the "underlying rationale and preliminary data in support of the research proposed" to the Komen Foundation, which is now providing Duke with a Promise Grant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.